John M. Evans

CIK 1786304 · CEO · last filed 2026-04-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$33.39M

Companies

2

Total Filings

31

Lifetime Open-Market Net

-$36.88M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BEAM CEO 1,150,205 $29.03 $33.39M -$36.88M 30 2026-04-06
Verve Therapeutics, Inc. (VERV) Delisted Director $11.13 $0 1 2022-06-13

Recent Filings · Page 2 of 4

31 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-04-03 BEAM Mixed −18,102 -$581.6K EDGAR
2024-04-01 BEAM Mixed +17,500 -$2.03M EDGAR
2024-02-02 BEAM Mixed −60,000 -$1.52M EDGAR
2023-04-05 BEAM Sell (S) −11,654 -$345.3K EDGAR
2023-03-31 BEAM Mixed +70,325 $100.0K EDGAR
2022-11-02 BEAM Sell (S) −50,000 -$2.32M EDGAR
2022-07-29 BEAM Sell (S) −50,000 -$3.29M EDGAR
2022-06-13 Verve Therapeutics, Inc. (VERV) Delisted Grant (A) $0 EDGAR
2022-05-02 BEAM Mixed +9,450 -$1.76M EDGAR
2022-04-04 BEAM Mixed +49,989 -$370.1K EDGAR
Showing 1120 of 31
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.